Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: A descriptive study

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Irfan, Seema ^a   Idrees, Faiza ^a   Mehraj, Vikram ^a   Habib, Faizah ^a   Adil, Salman ^a   Hasan, Rumina ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAPENEM; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; IMIPENEM; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; DESCRIPTIVE RESEARCH; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FUNGUS GROWTH; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PSEUDOMONAS AERUGINOSA; STATISTICAL SIGNIFICANCE; TREND STUDY; VANCOMYCIN RESISTANT ENTEROCOCCUS; BACTERIAL INFECTION; DRUG EFFECT; EVALUATION; FEVER; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; NEUTROPENIA; PAKISTAN;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CARBAPENEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; FEVER; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; NEUTROPENIA; PAKISTAN; VANCOMYCIN RESISTANCE;

EID: 47349104944     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-80     Document Type: Article

References (23)

1. Glasmacher A Von Lilienfeld-Toal M Schulte S Hahn C Schmidt-Wolf IG Prentice A An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients Clin Microbiol Infect 2005, 11:17-23. 10.1111/j.1469-0691.2005.01239.x 16138815
2. Walter T Hughes Dowald Armtrong Genald P Bodey Eric J Bow Arthur E Brown Thierry Calandra Guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 2002, 34:730-748. 10.1086/339215 11850858
3. Jones RN Contemporary antimicrobial susceptibility pattern of bacterial pathogens commonly associated with febrile patients with neutropenia Clin Infect Dis 1999, 29:495-502. 10.1086/520155 10530435
4. Sharma A Lokeshwar N Febrile neutropenia in haematological malignancies J Postgrad Med 2005, 51;42-48. 16519255
5. Wojak I Gospodarek E Analysis of microorganisms isolated from febrile neutropenic children with neoplastic disease Med Dosw Mikrobiol 2004 56 411 9 15959998
6. Ramphal R Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens Clin Infect Dis 2004, (Suppl 39):25-31. 10.1086/383048
7. Paul M Yahav D Fraser A Leibvici L Empirical antibiotic monotherapy for febrile neutropenia: Systematic review and met analysis of randomized control trials J Antimicrob Chemother 2006, 57:176-189. 10.1093/jac/ dki448 16344285
8. Hirakata Y Yamaguchi T Nakano M Izumikawa K Mine M Aoki S Kondoh A Matsuda J Hirayama M Yanagihara K Miyazaki Y Tomono K Yamada Y Kamihira S Kohno S Clinical and bacteriological charachteristics of IPM- type metallo-β-lactamase producing Pseudomonas aeruginosa Clin Infect Dis 2003, 37:26-32. 10.1086/375594 12830405
9. Sarwari A Hasan R Lim C Ng Y Ng C Zaman S PCR identification and automated ribotyping of Pseudomonas aeruginosa clinical isolates from intensive care patients Scandininavian J Infect Dis 2004, 36:342-349. 10.1080/00365540410020109 15287378
10. Noor A Hussain SF Risk factors associated with development of ventilator associated pneumonia JCPSP 2005, 15(2):92-95. 15730834
11. Khan E Sarwari A Hasan R Ghori S Babar I O'Brien F Grubb W Emergence of vancomycin resistant Enterococcus Faeium at a tertiary care hospital in Karachi, Pakistan J Hospital Infection 2002, 52:292-296. 10.1053/ jhin.2002.1315 12473475
12. Koneman EW Allen SD Janda WM Scherckenberger PC Winn JWC Color atlas and textbook of diagnostic microbiology Philadelphia Lippincott 6 2002 12778959
13. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing. 10th informational supplement National Committee for Clinical Laboratory Standards Wayne PA 2004
14. Karim M Khan W Farooqi B Malik I Bacterial isolates in neutropenic febrile patients J Pak Med Assoc 1991, 48:364-7. 1902530
15. Khan MA Siddiqui BK Shamim A Yosuf MA Ahmed A Zakiullah N Burney IA Emerging bacterial resistance pattern in febrile neutropenic patients: experience at atertiary care hospital in Pakistan J Pak Med Assoc 2004, 54:357-360. 15449917
16. Burney IA Farooqui BJ Siddiqui T Khurshid M The spectrum of bacterial infections in febrile neutropenic patients. The effect on empiric antibiotic therapy J Pak Med Assoc 1998, 48(12):364-7. 10531769
17. Gales AC Jones RN Forward KR Linares J Sader HS Verhoef J Emerging importance of multi-drug resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997-1999) Clin Infect Dis 2001, 32:S104-13. 10.1086/320183 11320451
18. Baskaran ND Gan GG Adeeba K Sam IC Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia Int J Infect Dis 2007, 11:513-7. 10.1016/j.ijid.2007.02.002 17459753
19. Wang FD Lin ML Liu CY Bacteremia in patients with hematological malignencies Chemotherapy 2005, 51:147-53. 10.1159/000085623 15886475
20. Chen CY Tang JL Hsueh PR Yao M Huang SY Chen YC Shen MC Wang CH Tsai W Chang SC Tien HF Luh KT Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy J Formos Med Assoc 2004, 103(7):526-32. 15318274
21. Eil-Mahallawy H Sidhom I El-Din NH Zamzam M El-Lamie MM Clinical and microbiological determinants of serious blood stream infections in Egyptian pediatric patients; One year study Int J Infect Dis 2005, 9(1):43-51. 10.1016/j.ijid.2003.11.010 15603994
22. Kline RM Baorto EP Treatment of pediatric febrile neutropenia in the era of vancomycin-resistant microbes Pediatr Blood Cancer 2005, 44:205-6. 10.1002/pbc.20224 15452913
23. Feld R Vancomycin as a part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancers: Pros and cons Clin Infect Dis 1999, 29:503-7. 10530436